FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1200311000001108: Sulfasalazine 250mg/5ml oral suspension 500 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22449701000001112 Sulfasalazine 250mg/5ml oral suspension 500 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22449801000001115 Sulfasalazine 250mg/5ml oral suspension 500 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sulfasalazine 250mg/5ml oral suspension 500 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Is pack of Product containing precisely sulfasalazine 50 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Has active ingredient Sulfasalazine false Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Has VMP Product containing precisely sulfasalazine 50 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Has specific active ingredient Sulfasalazine true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salazopyrin 250mg/5ml suspension (Pfizer Ltd) 500 ml Is a True Sulfasalazine 250mg/5ml oral suspension 500 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start